Cardiac Imaging: Page 292

FDA sets date to review Boston Scientific stent
By AuntMinnie.com staff writers
The Food and Drug Administration will hold a special panel hearing on November 20 to review Boston Scientific’s premarket approval (PMA) application for the Taxus Express2 paclitaxel-eluting coronary stent.
September 15, 2003
Molecular Insight Pharmaceuticals to start phase III trials
By AuntMinnie.com staff writers
Radioisotope imaging developer Molecular Insight Pharmaceuticals will proceed with phase III trials of its molecular imaging pharmaceutical, (123I)-BMIPP, for the visualization of cardiac metabolism.
September 14, 2003
Epix to present phase III results
By AuntMinnie.com staff writers
MRI contrast developer Epix Medical of Cambridge, MA, is scheduled to present the phase III clinical results of its MS-325 MRI contrast agent being co-developed by the firm and Schering of Berlin at he annual scientific Symposium of Transcatheter Cardiovascular Therapeutics (TCT) in Washington, DC.
September 14, 2003
GE upgrades Millennium MyoSight
By AuntMinnie.com staff writers
GE Medical Systems debuted the second generation of its Millennium MyoSight gamma camera at this week’s American Society of Nuclear Cardiology meeting.
September 14, 2003
Boston Scientific’s Taxus stent receives Canadian approval
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, has received approval from Health Canada’s Therapeutic Products Directorate for the sale of its Taxus Express2 paclitaxel-eluting coronary stent system in Canada.
September 11, 2003
Calcium-scoring methods study says it's all good
By Eric Barnes
Reassuring news in coronary calcium screening came out of Ohio State University in Columbus this month, where researchers have found that all of the principal calcium-scoring methods do a pretty good job of assessing the risk of coronary events.
September 9, 2003
Cordis stent gets FDA OK
By AuntMinnie.com staff writers
Interventional technology developer Cordis Endovascular has received Food and Drug Administration clearance for the use of its S.M.A.R.T. Nitinol stent and S.M.A.R.T. Control Nitinol stent for primary stenting of the iliac arteries.
September 4, 2003
Abbott Northwestern, Siemens form strategic alliance
By AuntMinnie.com staff writers
Abbott Northwestern Hospital of Minneapolis and Siemens Medical Solutions of Malvern, PA, have signed a 10-year partnership agreement for cooperative cardiac research and development activities.
August 27, 2003
Toshiba launches 16-slice cardiac CT scanner
By AuntMinnie.com staff writers
Multimodality vendor Toshiba America Medical Systems is introducing Aquilion 16 CFX, a new version of its Aquilion 16-slice CT scanner.
August 18, 2003
HealthTest launches second center
By AuntMinnie.com staff writers
Preventive imaging services provider HealthTest Scan Center has opened its second center.
August 13, 2003
Coronary calcium scan gains ground as prognostic tool
By Eric Barnes
Why do coronary calcium screening at all? It’s an appropriate question to ask Dr. Jerome Breen, a radiologist from the Mayo Clinic in Rochester, MN. Breen led the quest for an answer at the 2003 Symposium on Multidetector-Row CT in San Francisco.
August 5, 2003
EP MedSystems seeks 510(k) for integrated system
By AuntMinnie.com staff writers
Electrophysiology device developer EP MedSystems has requested a 510(k) regulatory clearance filing with the Food and Drug Administration for the integration of its WorkMate intracardiac ultrasound catheter system with Boston Scientific’s Realtime Position Management technology.
July 23, 2003
Previous Page
Page 292 of 325
Next Page